» Articles » PMID: 28127710

Vitamin D, Calcium, and Cardiovascular Disease: A"D"vantageous or "D"etrimental? An Era of Uncertainty

Overview
Publisher Springer
Date 2017 Jan 28
PMID 28127710
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

While the function of vitamin D in regulating calcium homeostasis is well established, there has been growing interest in its role in the prevention of numerous chronic diseases, including cardiovascular disease (CVD). There is mounting epidemiological evidence suggesting that vitamin D deficiency is linked to increased CVD risk. However, the results of previous vitamin D supplementation trials have yielded mixed results in regards to cardiovascular health, and the results of ongoing large-scale randomized controlled trials are not yet available. Further complicating the issue, calcium supplementation, which is often prescribed concurrently with vitamin D, has been associated with increased CVD risk in some (but not all) studies. Thus, it is currently unclear whether vitamin D supplements, particularly for those that are deficient, can help prevent the development of CVD. In addition, there has not been uniform consensus regarding the threshold of 25-hydroxyvitamin D levels that constitutes "sufficiency" across organizational guidelines. This review will provide an update on the most recent evidence regarding the effects of vitamin D and calcium supplements on CVD clinical outcomes, summarize ongoing vitamin D trials, and discuss the current but remarkably disparate recommendations regarding vitamin D deficiency screening and supplementation.

Citing Articles

The Co-Existence of Hypovitaminosis D and Diabetes Mellitus Triples the Incidence of Severe Coronary Artery Disease in Women.

Aleksova A, Janjusevic M, Pani B, Hiche C, Chicco A, Derin A J Clin Med. 2024; 13(22).

PMID: 39597936 PMC: 11594877. DOI: 10.3390/jcm13226792.


Bridging the gap: Navigating the impact of dietary supplements on abdominal aortic aneurysm progression- A systematic review.

Amirsardari Z, Khalili A, Behnoush A, Agahi S, Amirsardari F, Kohansal E PLoS One. 2024; 19(6):e0305265.

PMID: 38923975 PMC: 11207180. DOI: 10.1371/journal.pone.0305265.


Association of serum 25-hydroxyvitamin D levels with all-cause and cause-specific mortality among postmenopausal females: results from NHANES.

Shi J, Wu J, Zhu X, Zhou W, Yang J, Li M J Transl Med. 2023; 21(1):629.

PMID: 37715212 PMC: 10504740. DOI: 10.1186/s12967-023-04413-y.


Exploring the Role of Vitamin D in Atherosclerosis and Its Impact on Cardiovascular Events: A Comprehensive Review.

Khanolkar S, Hirani S, Mishra A, Vardhan S, Hirani S, Prasad R Cureus. 2023; 15(7):e42470.

PMID: 37637551 PMC: 10450567. DOI: 10.7759/cureus.42470.


How Do Minerals, Vitamins, and Intestinal Microbiota Affect the Development and Progression of Heart Disease in Adult and Pediatric Patients?.

Brecht P, Dring J, Yanez F, Styczen A, Mertowska P, Mertowski S Nutrients. 2023; 15(14).

PMID: 37513682 PMC: 10384570. DOI: 10.3390/nu15143264.


References
1.
Schleicher R, Sternberg M, Lacher D, Sempos C, Looker A, Durazo-Arvizu R . The vitamin D status of the US population from 1988 to 2010 using standardized serum concentrations of 25-hydroxyvitamin D shows recent modest increases. Am J Clin Nutr. 2016; 104(2):454-61. PMC: 4962157. DOI: 10.3945/ajcn.115.127985. View

2.
Cosman F, de Beur S, LeBoff M, Lewiecki E, Tanner B, Randall S . Clinician's Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int. 2014; 25(10):2359-81. PMC: 4176573. DOI: 10.1007/s00198-014-2794-2. View

3.
Lutsey P, Michos E, Misialek J, Pankow J, Loehr L, Selvin E . Race and Vitamin D Binding Protein Gene Polymorphisms Modify the Association of 25-Hydroxyvitamin D and Incident Heart Failure: The ARIC (Atherosclerosis Risk in Communities) Study. JACC Heart Fail. 2015; 3(5):347-356. PMC: 4426050. DOI: 10.1016/j.jchf.2014.11.013. View

4.
Beilfuss J, Berg V, Sneve M, Jorde R, Kamycheva E . Effects of a 1-year supplementation with cholecalciferol on interleukin-6, tumor necrosis factor-alpha and insulin resistance in overweight and obese subjects. Cytokine. 2012; 60(3):870-4. DOI: 10.1016/j.cyto.2012.07.032. View

5.
Pittas A, Dawson-Hughes B, Sheehan P, Rosen C, Ware J, Knowler W . Rationale and design of the Vitamin D and Type 2 Diabetes (D2d) study: a diabetes prevention trial. Diabetes Care. 2014; 37(12):3227-34. PMC: 4237973. DOI: 10.2337/dc14-1005. View